The Vigabatrin REMS Program is called for by the FDA to ensure notified risk-benefit decisions before initiating treatment, and to make sure appropriate use vigabatrin while patients are treated. When vision loss will certainly occur, it is not possible for your health care supplier to know.
The most typical adverse effects of SABRIL in youngsters 3 to 16 years is weight gain. With severe vision loss, you may only be able to see things directly before you (in some cases called tunnel vision"). You are at risk for vision loss with any kind of quantity of SABRIL.
Tell your doctor if you are expectant or mean to get pregnant. If vision testing can not be done, your doctor might proceed recommending SABRIL, yet will certainly not have the ability to watch for any vision loss. If vision tests are refrained from doing on a regular basis, your healthcare provider might quit recommending SABRIL for you (or your child).